Skip to content

Effects of different thermal intensities of capacitive-resistive electric transfer therapy on muscle function recovery after elbow flexor eccentric exercise: a randomized controlled trial

Effects of different thermal intensities of capacitive-resistive electric transfer therapy on muscle function recovery after elbow flexor eccentric exercise: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126179
Enrollment
Unknown
Registered
2026-06-04
Start date
2026-06-05
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

exercise induced muscle damage

Interventions

Sham group:The subject assumes the same positioning as in other groups. The therapist applies a conductive medium, places electrodes and a return plate, and moves the therapeutic electrodes along the
Non-thermal dose group for CAP-CRET:The CAP mode was employed for low-power capacitive-resistive energy transfer intervention.During the treatment, the subject should not experience any significant se
no significant skin heat, burning sensation, or discomfort is observed
record skin temperature before and after treatment, ensuring the increase in skin temperature remains within a low range.
Warm-dose group: CAP-CRET:The CAP mode was employed for medium-power capacitive-resistive energy transfer intervention.During the treatment, a stable, comfortable, and well-tolerated warm sensation is
no burning, tingling, or aggravated pain occurs
if the warmth sensation =7/10 or the subject experiences discomfort, immediately reduce the intensity or suspend the intervention
record skin temperature before and after treatment.

Sponsors

chengdu sport university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Subjects meeting the following criteria are proposed for inclusion: 1. Healthy adults aged 18–35 years, regardless of gender. 2. No regular upper limb resistance training experience in the past 12 weeks. 3. No history of musculoskeletal injuries to the elbow, shoulder, wrist, or upper limbs within the past 6 months. 4. Able to understand the research protocol and voluntarily sign the informed consent form. 5. Able to collaborate in performing isokinetic centrifugation exercises, continuous interventions, and follow-up measurements. 6. During the study period, participants agreed to avoid additional upper limb resistance training, strenuous exercise, massage, thermotherapy, cryotherapy, analgesics, or any other interventions that may interfere with recovery. 7. Female subjects must have a relatively regular menstrual cycle and agree to report the phase of their menstrual cycle in the study records; baseline testing and centrifugal exercise-induced tests should preferably be conducted during the early follicular phase (i.e., days 2–7 of menstruation) .

Exclusion criteria

Exclusion criteria: 1. History of upper limb fractures, tendon injuries, nerve injuries, severe muscle strains, or surgical interventions. 2. Presence of neurological disorders, muscular diseases, or rheumatic/immune diseases that affect upper limb motor function. 3. Presence of cardiovascular diseases, severe metabolic disorders, uncontrolled hypertension, or other conditions that make high-intensity eccentric exercise unsuitable. 4. Recent presence of acute inflammation, infection, fever, or general malaise. 5. Do not take nonsteroidal anti-inflammatory drugs, analgesics, muscle relaxants, or any other medications that may affect pain and inflammatory responses within 7 days prior to the study. 6. Engaged in intense upper limb exercise, resistance training, massage, thermotherapy, cryotherapy, or other recovery interventions within 48–72 hours prior to the study. 7. Presence of skin lesions, dermatitis, infection, sensory impairment, or allergy to conductive materials. 8. Implantation of a cardiac pacemaker, metallic internal fixation devices, or other implantable devices unsuitable for radiofrequency/electrical therapy intervention. 9. Women during pregnancy, lactation, or preconception period. 10. Female subjects with significantly irregular menstrual cycles, dysmenorrhea severely affecting athletic performance, or recent use of medications that may substantially alter hormone levels without achieving stable control.

Design outcomes

Primary

MeasureTime frame
Maximum isometric contraction torque;Painless joint range of motion;

Secondary

MeasureTime frame
VAS Pain Score;

Countries

China

Contacts

Public ContactYang Jinfeng

chengdu sport university

yangjinfeng@cdsu.edu.cn+86 158 8369 0066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026